Eris Lifesciences Closes Trading Window for Insider Trading Compliance

Eris Lifesciences Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will be shut from October 01, 2026, and will reopen 48 hours after the declaration of the company's unaudited financial results for the quarter and half-year ending September 30, 2026. All concerned individuals are advised against trading in the company's securities during this period. This notice is independent of any other trading window closure announcements.